Inventor · disambiguated record
Mieczyslaw A. Piatyszek
Also filed as: PIATYSZEK MIECZYSLAW A
9 granted patents·4 pending applications·262 citations·filing 1996–2025
89Inventor score
Top patents by PatentIndex Score
13 records- 0195US6518268B1Telomerase inhibitors and methods of their useGERON CORP·Filed 2000·Granted Feb 11, 2003·59 cites·33 claims
- 0290US6046307AModulation of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1997·Granted Apr 4, 2000·75 cites·11 claims
- 0389US6015710AModulation of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1996·Granted Jan 18, 2000·78 cites·8 claims
- 0485US7226744B2Assays for TERT promoter modulatory agents using a telomerase structural RNA componentSIERRA SCIENCES INC·Filed 2005·Granted Jun 5, 2007·5 cites·22 claims
- 0584US6599728B2Second mammalian tankyraseGERON CORP·Filed 2001·Granted Jul 29, 2003·13 cites·22 claims
- 0677US6294650B1Inhibition of mammalian telomerase by peptide nucleic acidsUNIV TEXAS·Filed 1999·Granted Sep 25, 2001·30 cites·13 claims
- 0774US11701374B18-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expressionANDREWS WILLIAM H·Filed 2011·Granted Jul 18, 2023·2 cites·4 claims
- 0870US12168019B18-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expressionSIERRA SCIENCES INC·Filed 2022·Granted Dec 17, 2024·0 cites·17 claims
- 0967US2025120956A1Azole Compounds for Enhancing Telomerase Reverse Transcriptase (TERT) ExpressionSIERRA SCIENCES INC·Filed 2024·Application pending·0 cites
- 1057US12404304B1Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the sameSIERRA SCIENCES LLC·Filed 2020·Granted Sep 2, 2025·0 cites·4 claims
- 1155US2008166711A1Assays for TERT promoter modulatory agentsANDREWS WILLIAM H·Filed 2007·Application pending·0 cites
- 1251US2009143451A1Compounds that increase telomerase reverse transcriptase (tert) expression and methods for using the sameANDREWS WILLIAM H·Filed 2008·Application pending·0 cites
- 1351US2025179122A1Telomerase Reverse Transcriptase (TERT) Expression Enhancing Compounds and Methods for Using the SameSIERRA SCIENCES LLC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →